[1]
KOTA, S.S.N. and Bandhakavi, S. 2023. COST-EFFECTIVENESS OF COMBINATION ANTI-CANCER DRUG THERAPY IN THE MANAGEMENT OF HER2-POSITIVE BREAST CANCER: A META-ANALYSIS. Asian Journal of Pharmaceutical and Clinical Research. 16, 12 (Dec. 2023), 20–25. DOI:https://doi.org/10.22159/ajpcr.2023.v16i12.48522.